Eye Health News and Research

Latest Eye Health News and Research

Pristine Solutions acquires Eaton Scientific Systems

Pristine Solutions, Inc. is pleased to announce that the Company has completed the acquisition of Eaton Scientific Systems, Ltd., a biomedical product development company focused on women's health solutions.

27 Aug 2012

Merz acquires CUVPOSA oral solution to treat children with cerebral palsy

Merz, Inc. today announced the acquisition of CUVPOSA (glycopyrrolate) oral solution for pediatric chronic severe drooling associated with neurologic conditions such as cerebral palsy.

27 Aug 2012

Mexican-Americans with ancestral links have higher insulin resistance levels

Mexican-Americans with an ancestral link to Amerindian tribes were found to have higher insulin resistance levels, which is an indication of several chronic conditions such as type 2 diabetes, according to research by The University of Texas Health Science Center at Houston (UTHealth).

26 Aug 2012

Heating as well as cleaning contact lens cases kills bacteria best

Heating contact lens cases to a temperature of 60°C while disinfecting with a multipurpose disinfecting solution could improve case hygiene by killing biofilms created by bacteria, report Australian researchers.

24 Aug 2012

Guidelines for parents to beat back-to-school bugs

School bells are beginning to sound again across the country, so it will only be a matter of time until every parent comes face-to-face with a child who wakes up with a cold, fever or upset stomach.

24 Aug 2012

'ESASO Course Series’ for ophthalmologists

In the new book series 'ESASO Course Series', the essentials of the courses of the European School for Advanced Studies in Ophthalmology (ESASO) are made available to interested ophthalmologists, optometrists, technicians and residents all over the world.

23 Aug 2012

Simple eye tracking test could hold key to early Alzheimer's diagnosis

A simple eye tracking test could hold the key to earlier Alzheimer's diagnosis, according to new research published today in the Journal of the American Aging Association.

23 Aug 2012

Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

A child's smile is something we take for granted. But muscle dysfunction can turn a simple expression of joy into a challenge. Surface electromyography provides a noninvasive method of sensing muscle activity that can be used for muscle rehabilitation—and to bring a smile to a child's face.

22 Aug 2012

Arteriocyte receives NIH grant for use of NANEX platform in bone marrow transplant

Arteriocyte, a leading clinical stage biotechnology company developing cellular based therapies to treat human diseases, announced today the successful award of another grant by the National Institute of Health for the use of the NANEX platform in Hematopoietic Reconstitution Using Ex Vivo Expanded Umbilical Cord Blood CD34+ Stem Cells.

22 Aug 2012

Study identifies how genetic mutations in the nervous system cause Duane Syndrome

A research team from King's College London and the University of Exeter Medical School has identified how a genetic mutation acts during the development of nerves responsible for controlling eye muscles, resulting in movement disorders such as Duane Syndrome, a form of squint.

22 Aug 2012

Molecular Partners, Allergan to develop and commercialize DARPins against ophthalmic diseases

Allergan, Inc. and Molecular Partners AG today announced that they have significantly expanded their existing relationship by entering into two separate agreements to discover, develop, and commercialize proprietary therapeutic DARPin products for the treatment of serious ophthalmic diseases.

21 Aug 2012

Study identifies mode of death of cone photoreceptor cells in animal model of RP

Research conducted at the Angiogenesis Laboratory at Massachusetts Eye and Ear Infirmary, has for the first time, identified the mode of death of cone photoreceptor cells in an animal model of retinitis pigmentosa (RP).

21 Aug 2012

Encouraging results from Ocular Therapeutix's travoprost Phase II trial on glaucoma

Following encouraging results from Ocular Therapeutix's travoprost punctum plug feasibility study, the company is now entering a pilot Phase II clinical trial to examine a two-month sustained release drug (OTX-TP2) for the treatment of ocular hypertension and glaucoma.

21 Aug 2012

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

Australian infectious disease therapy and vaccine development company BioDiem Ltd (ASX: BDM) announced today successful results from two programs of work carried out by French partner VIVALIS (NYSE Euronext: VLS), confirming the ability of BioDiem’s Live Attenuated Influenza Virus (LAIV) to grow in VIVALIS’ proprietary EB66® cell line.

20 Aug 2012

New book on malaria tells story of Plasmodium falciparum Genome Project

Few infectious diseases can rival malaria's ability to kill and cripple. Each year the disease causes hundreds of millions of people to be sickened and more than a million - mostly African children under the age of five - die.

18 Aug 2012

Pennsylvania Department of Health reports four confirmed and six probable cases of H3N2v flu

The Pennsylvania Department of Health today reported four confirmed and six probable human cases of influenza due to a new strain of the flu known as H3N2v.

18 Aug 2012

Overcorrection is a risk in pediatric exotropia surgery

One-third of pediatric patients treated surgically for intermittent exotropia have excellent post-treatment alignment, and two-thirds have satisfactory control of the condition after the procedure, show UK study results.

17 Aug 2012

Age, drugs, and disease alter sleep in Parkinson’s disease

Sleep patterns in patients with Parkinson’s disease are affected by age, disease severity, and dopamine agonists, German research indicates.

17 Aug 2012

New DNA sequencing tests improve ability to analyze genetic disorders

Scientists at the University of Medicine and Dentistry of New Jersey-New Jersey Medical School (UMDNJ-NJMS) have developed new DNA sequencing tests that hold significant promise for decreasing costs associated with diagnosing cancer and hereditary diseases, including cysticfibrosis.

17 Aug 2012

Preliminary results from Lexicon’s Phase 1 studies of LX2931 and LX7101 for RA

Lexicon Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering breakthrough treatments for human disease, today reported preliminary results from Phase 1 studies of LX2931 and LX7101.

17 Aug 2012

Eye Health News and Research

Latest Eye Health News and Research

Pristine Solutions acquires Eaton Scientific Systems

Merz acquires CUVPOSA oral solution to treat children with cerebral palsy

Mexican-Americans with ancestral links have higher insulin resistance levels

Heating as well as cleaning contact lens cases kills bacteria best

Guidelines for parents to beat back-to-school bugs

'ESASO Course Series’ for ophthalmologists

Simple eye tracking test could hold key to early Alzheimer's diagnosis

Surface electromyography can rehabilitate muscles in children with cranial nerve palsy

Arteriocyte receives NIH grant for use of NANEX platform in bone marrow transplant

Study identifies how genetic mutations in the nervous system cause Duane Syndrome

Molecular Partners, Allergan to develop and commercialize DARPins against ophthalmic diseases

Study identifies mode of death of cone photoreceptor cells in animal model of RP

Encouraging results from Ocular Therapeutix's travoprost Phase II trial on glaucoma

BioDiem and French partner VIVALIS a step forward in developing vaccines for diseases and related cancers

New book on malaria tells story of Plasmodium falciparum Genome Project

Pennsylvania Department of Health reports four confirmed and six probable cases of H3N2v flu

Overcorrection is a risk in pediatric exotropia surgery

Age, drugs, and disease alter sleep in Parkinson’s disease

New DNA sequencing tests improve ability to analyze genetic disorders

Preliminary results from Lexicon’s Phase 1 studies of LX2931 and LX7101 for RA

Genetics & Genomics - Second Edition eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Eye Health News and Research

Latest Eye Health News and Research

Genetics & Genomics - Second Edition eBook

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Newsletters you may be interested in